Weifuchun tablet for stomach precancer reversal
Treatments studied
Part of Digestive system clinical trials.
This study tests if Weifuchun tablets can reverse precancerous changes called gastric intestinal metaplasia. If you have this condition and no H. pylori infection, you may qualify.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 to 75 years old
- Diagnosed with advanced-stage stomach lining changes (OLGIM stage II to IV) in the last 3 months
- No current H. pylori infection (if treated, must be confirmed cleared)
- No regular use of NSAIDs (like ibuprofen) or statins (cholesterol drugs)
- No stomach surgery or cancer history
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if ursodeoxycholic acid can reverse intestinal metaplasia (a precancerous stomach condition) in patients who have no H. pylori infection. The goal is to see if this medication can help lower the risk of stomach cancer.
This study tests whether berberine, a natural compound, can help reverse or slow the progression of gastric intestinal metaplasia, a precancerous condition in the stomach lining. Participation involves taking the medication and monitoring your stomach health over time.
This trial tests whether a treatment can reverse stomach lining changes called GIM that increase cancer risk. It's for people who have had a past H. pylori infection but no current stomach cancer, and whose GIM has certain high-risk features.
This study tests a medicine called pyrvinium to see if it can reverse early changes in the stomach lining that may lead to stomach cancer. It may help prevent stomach cancer from developing.
This trial tests a Chinese herbal medicine called Shenbai Granules to see if it can prevent high-risk colon polyps from turning into cancer. If you have had such a polyp removed and fit the traditional Chinese medicine pattern, you may be able to join.
This trial tests whether taking aspirin after endoscopic removal of an early stomach condition can lower the chance of the cancer coming back or progressing. You may be considered if your early stomach findings were fully removed and you’re able to avoid certain medications that raise bleeding risk.
Hear when a new Gastric Intestinal Metaplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.